False-positive cancer screens and health-related quality of life

Cancer Nursing

Volumn 27, Issue 5, 2004, Pages 347-352

  McGovern, Patricia M ^a   Gross, Cynthia R ^b   Krueger, Richard A ^c   Engelhard, Deborah A ^a   Cordes, Jill E ^a   Church, Timothy R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer screening; Focus groups; Prostate, lung, colorectal, and ovarian cancer; Quality of life; Secondary prevention

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL ARTICLE; COLORECTAL CANCER; DIAGNOSTIC ERROR; DISTRESS SYNDROME; FEMALE; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; LABORATORY TEST; LUNG CANCER; MALE; NURSE; ONCOLOGY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RELIABILITY; VISUAL ANALOG SCALE;

EID: 5444272993     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200409000-00003     Document Type: Article

References (13)

1. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-481.
2. Gohagan JK. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21:249S.
3. Reis LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, Md: National Cancer Institute; 2003. Available at: http://seer.cancer.gov/CSR/1975_2000/index.html.
4. Miller BA, Kolonel LN, Bernstein L, Young JL Jr, Swanson GM, West D, et al, eds. In: United States Racial/Ethnic Cancer Patterns in the US, 1988-1992. Bethesda, Md: National Cancer Institute. Available at: http://www.cancer.gov/ publications/ethnicity/citation.html.
5. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21:2515-2725.
6. Domonitz JA, Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol. 1997;92:2171-2178.
7. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211-218.
8. Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS. Colorectal cancer screening beliefs. Cancer Pract. 2000;8:32-37.
9. Kaplan RM. Decisions about prostate cancer screening in managed care. Curr Opin Oncol. 1997;9:480-486.
10. Morgan DL, Krueger RA. The Focus Group Kit. Vols 1-6. Thousand Oaks, Calif: Sage; 1998.
11. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
12. Kind P. The EuroQOL instrument: an index of health-related quality of life. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven; 1996:191-196.
13. Weinberger M, Ferguson JA, Westmoreland G, et al. Can raters consistently evaluate the content of focus groups? Soc Sci Med. 1998;46:929-993.